The sNDA submission is based on positive results from Studies 501 and 502 demonstrating CAPLYTA’s robust antidepressant efficacy and favorable…
HO CHI MINH CITY, Vietnam, Nov. 29, 2024 /PRNewswire/ -- After several years of intensive investment in R&D, TMA Solutions launched…
Two top healthcare awards underline Brainomix's landmark achievements in 2024 and the validation of its software's impact on treatment ratesOXFORD,…
TORONTO, ON / ACCESSWIRE / November 27, 2024 / Theralase® Technologies Inc. (" Theralase® " or the " Company ")…
WOBURN, Mass., Nov. 26, 2024 /PRNewswire/ -- Report by Parlance: In October 2024, Hurricane Milton ravaged Florida's Gulf Coast, leaving…
MIAMI, FL, Nov. 26, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on…
Contract Unlocks Significant Market Opportunities Across Federal Healthcare SystemsROSELAND, N.J., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:…
After a successful 6-week pilot program, Nabla's ambient AI assistant is rolling out to Catalight's clinical team of case managers,…
NEW YORK, Nov. 25, 2024 /PRNewswire/ -- The global benefits administration service market size is estimated to grow by USD 144.7…
Presentations include first reporting of data for the RESET™ Clinical Trial evaluating SPRINT PNS versus Standard Interventional Management for low…